Leukemoid reaction in sarcomatoid renal cell carcinoma: a two-case report by unknown
WORLD JOURNAL OF 
SURGICAL ONCOLOGY 
Huang et al. World Journal of Surgical Oncology 2014, 12:100
http://www.wjso.com/content/12/1/100CASE REPORT Open AccessLeukemoid reaction in sarcomatoid renal cell
carcinoma: a two-case report
Weiping Huang†, Feng Wang†, Yeping Li, Feifei Duan and Zhixian Yu*Abstract
Leukemoid reaction is defined as reactive leukocytosis exceeding 40 × 109/l, with a significant increase in early
neutrophil precursors, and can be a paraneoplastic manifestation of various malignant tumors. Leukemoid reaction
is a sign for poor prognosis in solid tumors so is sarcomatoid renal cell carcinoma (SRCC) when compared to more
differentiated histologies. Here, we are reporting two cases of leukemoid reaction after radical nephrectomy, both
of which were diagnosed as SRCC pathologically. The operations were successful: no complications were observed
and the patients were discharged in good condition. However, a few weeks later, the white blood cell (WBC) count
gradually increased. Even though routine management was done immediately, the count was still elevating. A
diagnosis of a leukemoid reaction was established and both of them died shortly thereafter. Due to the poor
prognosis of most patients with malignant leukemoid reaction, leukemoid reaction may be a predictor of prognosis
in patients with SRCC, but more data are needed.
Keywords: Leukemoid reaction, Sarcomatoid, Renal cell carcinomaBackground
Leukemoid reaction refers to a reactive leukocytosis,
which has been described in response to inflammation,
severe or disseminated infection, tissue destruction or
other marrow stimulants. Leukemoid reaction is a sign
for poor prognosis in solid tumors and so is sarcomatoid
renal cell carcinoma (SRCC) when compared to more
differentiated histologies. SRCC is a rare but very aggres-
sive variant of renal cell carcinoma (RCC) which used to
be thought of as a primary renal sarcoma. Since these
tumors co-express both epithelial and stromal markers,
they are now believed to represent a form of dedifferen-
tiated carcinoma. As SRCC is highly resistant to chemo-
therapy and easily metastases, many patients died
shortly after diagnosis. Leukemoid reactions have been
described mainly in association with lung, gastrointes-
tinal, bladder and head and neck cancers, but have rarely
been described in association with SRCC. To our
knowledge, these are the first two cases report to do
so. The characteristics of both patients are described
in Tables 1 and 2.* Correspondence: fengyuan-@163.com
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Case one
A 36 year old woman presented with left flank pain for
one month. The patient was admitted to the First Affili-
ated Hospital of Wenzhou Medical University and
underwent serial examinations. Physical examination
showed a left flank mass with tenderness. An abdominal
computed tomography (CT) scan showed a mass meas-
uring 8 × 10 cm in the left kidney (Figure 1A). Her initial
white blood cell (WBC) count was 48 × 109/l, she did
not complain of fever, and her bone marrow smear did
not show myeloproliferative process. A septic workup,
including chest x-ray, blood culture, and urine culture
were all negative. She underwent radical nephrectomy
and the pathologic diagnosis was SRCC (Figure 2A). No
complication developed and the course of treatment was
uneventful. However, the WBC count gradually in-
creased (Figure 3A) and the body temperature was high
(37.9 to 40.5°C). She was treated with systemic antibi-
otics and the temperature decreased but the WBC count
remained high. Due to the high WBC count, a workup
for chronic myeloid leukemia (CML) was initiated. The
lactic dehydrogenase (LDH) level was 351. The leukocyte
alkaline phosphatase (LAP) score was 280. A peripheral
smear showed numerous segmented neutrophils andLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.












Red blood cell 3.43*10^12/L
Hb 102 g/L
Platelet 110*10^9/L
White blood cell 47.2*10^9/L
NEUT% 89.2
Lactate dehydrogenase 1075 U/L
Alkaline phosphatse 434 U/L
Operation nephrectomy
free margins with 2/7 positive




Reason for death multiple organ failure













Red blood cell 3.23*10^12/L
Hb 98 g/L
Platelet 258*10^9/L
White blood cell 30.2*10^9/L
NEUT% 91.3
Lactate dehydrogenase 558 U/L
Alkaline phosphatse 289U/L
Operation nephrectomy
free margins with 0/5 negative




Reason for death multiple organ failure
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supporting either a hematological neoplasia, or the pres-
ence of infiltration by tumor cells. Cytogenetic studies
were normal. A PCR(Polymerase Chain Reaction) for
BCR-ABL fusion transcript was negative. A diagnosis of
a leukemoid reaction was confirmed and she died of
multiple organ failure shortly there after at six weeks
postoperatively.
Case 2
The patient, a 56 year old male, complained about more
than half a month’s history of right flank pain and fever.
He had no systemic and lower urinary tract symptoms
and was admitted to the First Affiliated Hospital of
Wenzhou Medical University for further examinations.
The patient started with a high fever (38.5 to 41.0°C).
His first WBC count was 26.9 × 109/L. A tender, palpable
right flank mass with an acute percussion pain was de-
tected during a physical examination. His CT scan
showed a solid hypo dense lesion in the right kidney
measuring 7 × 10 cm (Figure 1B). Meanwhile, a right
renal tumor was identified with no evidence of extra-renal extension or distant metastases. An open right rad-
ical nephrectomy was performed via a supra-11th rib
right flank incision. The tumor was pathologically diag-
nosed as SRCC (Figure 2B). Postoperative recovery was
uncomplicated and white blood cell decreased gradually
to the normal range. However, two weeks later after the
patient was discharged, he presented with a high fever
again once more. Even though broad-spectrum antibiotics
were administered without delay, the increasing speed of
the WBC count was dramatic (Figure 3B). Leukemoid re-
action was established and the patient died of multiple
organ failure less than 50 days after the operation.
Conclusions
Leukemoid reaction is firstly defined by Krumbhaar to
describe a phenomenon concerning patients with blood
findings that resembling some type of leukemia, but in
whom leukemia is not confirmed through the subse-
quent course of the illness [1]. There is also a more
restrictive definition in which the WBC count exceed-
ing 40.000/ul is associated with a cause outside the
bone marrow, or a certain proportion of blast cells are
Figure 1 Scans of the left kidney mass. A. CT scan: a mass measuring 8 × 10 cm in the left kidney. B. MR: A giant abnorminal signal in the
right kidney, measuring 9 × 10 cm. Hydronephrosis existed.
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ably caused by mechanical stimuli on bone marrow,
resulting from bone metastases. They may also be
caused by humoral stimuli resulting from neosynthe-
sized blastic factors, or factors released from the foci of
tumor necrosis.
Leukemoid reactions in carcinoma have often been de-
scribed in association with carcinomas of the stomach,
colon, liver, gall bladder, pancreas, lung, bladder, bone,
and thyroid gland [3-8]. They have been reported in
association with renal cell carcinoma RCC [9], but not
with SRCC. To our knowledge, it is the first time that a
leukemoid reaction has been reported in association
with SRCC.
Both of the two patients had fever during the treat-
ment and observation process. However, fever is an inte-
gral component of a leukemoid reaction, often
associated with other paraneoplastic syndromes, result-
ing from either a release of endogenous pyrogens or dueFigure 2 Pathological examination of sarcomatoid renal cell carcinom
pathological examination. B. Sarcomatoid renal cell carcinoma was confirmto necrotic-inflammatory phenomena of the tumor [10].
Standard antipyretic drugs and antibiotics are usually
ineffective. Interleukin I (IL-1) and tumor necrotic fac-
tor (alpha) centrally acting on the thermoregulatory
center of the hypothalamus are the major endogenous
pyrogens [11,12].
A granulocyte colony-stimulating factor (G-CSF)
driven reaction is usually seen in advanced local or
metastatic disease. It is thought to be associated with
tumor progression and necrosis. With the function of
this auto–production hematopoietic growth factor,
precursor cells in the bone marrow are stimulated to
proliferation and maturation into fully differentiated
neutrophils [13,14]. Generally, the WBC count will de-
crease to the normal range if the cause of a leukemoid
reaction is eliminated. However, in these two patients,
tumor resection did not result in the return of the
WBC count. The final WBC count before death was ex-
tremely high.a cells. A. Sarcomatoid renal cell carcinoma was confirmed by the
ed by the pathological examination.
Figure 3 WBC count graphs showing WBC count was record down when patients were admitted to hospital. A. WBC gradually increased
postoperatively. Δ represents the first day patient underwent radical nephrectomy. ○ represents the day patient was discharged from hospital. B.
WBC count gradually increased postoperatively. Δ represents the first day the patient underwent radical nephrectomy. ○ represents the day the
patient was discharged from hospital. L, liter; WBC, white blood count.
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logic subtypes of RCC, with the incidence ranging from
1.2% to 23.6% [15]. It is uniformly associated with a poor
prognosis, with a median survival ranging from 2 to
9 months [15-17]. Surgery, alone, is often inadequate to
cure patients, although there is no proven rule for adju-
vant therapy. We performed a review of SRCC treatment
these 10 years, finding that there was a case report indi-
cating that sunitinib could be helpful for advanced SRCC
[18]. Whether the application of tyrosin-kinase inhibi-
tors such as sunitinib would be beneficial for a leuke-
moid reaction in SRCC is unclear, but worth trying.
These two cases indicate that leukemoid reaction may
be a predictor of prognosis in patients with SRCC. Due
to most of the patients with a malignant leukemoid reac-
tion having a poor prognosis, it should always keep in
mind that the sarcomatoid possibility of the tumor ori-
gin when there is an unknown etiology of leukecytosis,
especially when infection is not likely. Clearly, more data
and evidence are still needed to carry out extensive
hematological diagnostic tests in order to distinguish the
cause of the leukemoid reaction which would make it
easier to find an effective adjuvant therapy.Consent
Written informed consent was obtained from these
two patient for publication of this two case report and
any accompanying images. A copy of the written con-
sent is available for review by the Editor-in-Chief of
this journal.
Abbreviations
SRCC: sarcomatoid renal cell carcinoma; WBC: white blood cell; RCC: renal
cell carcinoma; CML: myeloid leukemia; LAP: alkaline phosphatase;
PCR: Polymerase Chain Reaction; G-CSF): granulocyte colony-stimulating
factor.
Competing interest
The authors declare that there is no conflict of interest.
Authors’ contributions
WH: conception and design of the study, acquisition of data, and
interpretation of data. WHFW: drafting the manuscript and revising it
critically for important content. YL: drafting the manuscript and revising it
critically for important content. FD: finished partial manuscript and
translation. ZY: conception and coordination of the study. All authors have
read and approved the final manuscript.
Authors’ information
Weiping Huang and Feng Wang: Co-first coauthors.
Huang et al. World Journal of Surgical Oncology 2014, 12:100 Page 5 of 5
http://www.wjso.com/content/12/1/100Acknowledgments
We thank Dr Xiaohua Zhang for his generous help in manuscript revision.
This work has not been published in any other journal or publication.
Received: 29 June 2013 Accepted: 15 March 2014
Published: 19 April 2014
References
1. Krumbhaar EB: Leukemoid blood picture in various clinical conditions.
Am J Med Sci 1926, 172:519.
2. Hoffman R, Furie B, Benz EJ, McGlave P, Silberstein LE, Shattil SJ:
Hematology: basic principles and practice. Volume 702. 5th edition.
Philadelphia: Churchill Livingstone; 2009.
3. Riesenberg H, Müller F, Görner M: Leukemoid reaction in a patient with
adenocarcinoma of the lung: a case report. J Med Case Rep 2012, 6:211.
4. Ma X, Li G, Cai Z, Sun W, Liu J, Zhang F: Leukemoid reaction in malignant
bone tumor patients - a retrospective, single-institution study.
Eur Rev Med Pharmacol Sci 2012, 16:1895–189.
5. Boşoteanu C, Boşoteanu M, Aşchie M: Differential diagnosis issues in a
case of gastric carcinoma associated with leukemoid reaction.
Rom J Morphol Embryol 2009, 50:701–705.
6. Perez FA, Fligner CL, Yu EY: Rapid clinical deterioration and leukemoid
reaction after treatment of urothelial carcinoma of the bladder: possible
effect of granulocyte colony-stimulating factor. J Clin Oncol 2009,
27:e215–e217.
7. Saussez S, Heimann P, Vandevelde L, Bisschop P, Jortay A, Schandene L,
Cogan E: Undifferentiated carcinoma of the nasopharynx and leukemoid
reaction: report of case with literature review. J Laryngol Otol 1997,
111:66–69.
8. Qureshi KM, Raman AK, Tan D, Fakih MG: Leukemoid reaction in
pancreatic cancer: a case report and review of the literature. JOP 2006,
7(6):631–4.
9. Lalani AP, Asgaonkar DS, Yadav JN, Dalal D, Borges NE, Deshpande DV:
Renal cell carcinoma: presenting with congestive hepatosplenomegaly
and rare haematological complications. J Assoc Physicians India 1990,
38:179–180.
10. Sakka V, Tsiodras S, Giamarellos-Bourboulis EJ, Giamarellou H: An update on
the etiology and diagnostic evaluation of a leukemoid reaction.
Eur J Intern Med 2006, 17:394–398.
11. Kim BR, Yang EK, Kim DY, Kim SH, Moon DC, Lee JH, Kim HJ, Lee JC:
Generation of anti-tumour immune response using dendritic cells pulsed
with carbonic anhydrase IX-Acinetobacter baumannii outer membrane
protein A fusion proteins against renal cell carcinoma. Clin Exp Immunol
2012, 167:73–83. doi:10.1111/j.1365-2249.2011.04489.
12. Kaur G, Athar M: Alam MS Dietary supplementation of silymarin protects
against chemically induced nephrotoxicity, inflammation and renal
tumor promotion response. Invest New Drugs 2010, 28:703–713.
doi:10.1007/s10637-009-9289-6.
13. Tachibana M, Miyakawa A, Tazaki H, Nakamura K, Kubo A, Hata J, Nishi T,
Amano Y: Autocrine growth of transitional cell carcinoma of the bladder
induced by granulocyte-colony stimulating factor. Canc Res 1995,
55:3438–3443.
14. Lieschke GJ, Burgess AW: Granulocyte-colony stimulating factor and
granulocyte-macrophage colony stimulating factor. N Engl J Med 1992,
327:99–106.
15. de Peralta-Venturina M, Moch H, Amin M, Tamboli P, Hailemariam S,
Mihatsch M, Javidan J, Stricker H, Ro JY, Amin MB: Sarcomatoid
differentiation in renal cell carcinoma: a study of 101 cases.
Am J Surg Pathol 2001, 25:275–284.
16. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML: Comparisons of
outcome and prognostic features among histologic subtypes of renal
cell carcinoma. Am J Surg Pathol 2003, 27:612–624.17. Mian BM, Bhadkamkar N, Slaton JW, Pisters PW, Daliani D, Swanson DA,
Pisters LL: Prognostic factors and survival of patients with sarcomatoid
renal cell carcinoma. J Urol 2002, 167:65–70.
18. Tsuchiyama K, Ito H, Ishida H, Itoh H, Yokoyama O: Advanced sarcomatoid
renal cell carcinoma effectively treated with sunitinib: report of a case.
Hinyokika Kiyo 2011, 57:615–618.
doi:10.1186/1477-7819-12-100
Cite this article as: Huang et al.: Leukemoid reaction in sarcomatoid
renal cell carcinoma: a two-case report. World Journal of Surgical Oncology
2014 12:100.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
